Illinois SB 3222 Restricts Intoxicating Hemp Sales, Expands Equity
New Illinois legislation bans intoxicating hemp products while broadening cannabis social equity provisions.

The iconic United States Capitol dome framed by lush green trees on a sunny day.
Bill Targets Intoxicating Hemp Loophole
SB 3222 prohibits retail sales of hemp-derived products containing intoxicating cannabinoids, closing a regulatory gap exploited by gas stations and convenience stores. The measure defines "intoxicating hemp" as any hemp product with detectable levels of delta-9 THC, delta-8 THC, or other psychoactive cannabinoids above trace amounts. Illinois joins more than a dozen states that have moved to restrict intoxicating hemp sales since the 2018 Farm Bill federally legalized hemp with less than 0.3% delta-9 THC by dry weight.
The bill passed the Illinois Senate 38-15 on June 28. The House followed 72-41 on July 1. Pritzker hasn't indicated whether he'll sign the measure, though his administration supported similar restrictions in prior sessions.
Illinois Department of Agriculture currently oversees hemp cultivation under the state's federally approved plan, but it lacks authority to regulate downstream retail products. SB 3222 shifts enforcement of intoxicating hemp retail to the Illinois Department of Financial and Professional Regulation, which already oversees adult-use cannabis dispensaries.
Social Equity Provisions Expanded
The legislation broadens eligibility for Illinois's cannabis Social Equity Program by lowering income thresholds and expanding qualifying arrest records. Applicants with household income at or below 250% of the federal poverty level now qualify, down from the current 300% threshold. The bill also includes individuals arrested for—but not convicted of—cannabis offenses, a category previously excluded from the program.
Illinois launched its Social Equity Program in 2020 to prioritize dispensary licenses for applicants from communities disproportionately affected by cannabis prohibition. The program has awarded 185 conditional licenses to date, though fewer than 60 have opened for business due to financing and real estate obstacles.
Compliance Timeline for Hemp Retailers
Retailers selling intoxicating hemp products face a six-month compliance window after the bill becomes law. The grace period allows existing inventory to be sold down or transferred to licensed cannabis dispensaries, which remain the only legal channel for intoxicating cannabinoid sales under the Cannabis Regulation and Tax Act.
Violations after the compliance period carry civil penalties of up to $10,000 per occurrence. Repeat offenders face potential criminal misdemeanor charges. The bill doesn't criminalize possession or personal use of intoxicating hemp products, only retail distribution.
Industry Response Split Along License Lines
Licensed cannabis operators supported the bill, while hemp retailers and trade groups opposed it as overreach. The Illinois Cannabis Regulation Oversight Officer, an industry advocacy group representing licensed MSOs and craft growers, testified in favor during committee hearings. Representatives argued that unregulated hemp products undercut the state's taxed and tested cannabis market.
The hemp loophole has siphoned an estimated $200 million annually from Illinois's regulated cannabis market, according to industry estimates submitted during legislative testimony.
Hemp trade associations, including the U.S. Hemp Roundtable's Illinois chapter, opposed the measure as a de facto ban that ignores federal law. They argued that the 2018 Farm Bill permits interstate hemp commerce and that Illinois can't prohibit products legal under federal statute.
Federal Preemption Question Unresolved
Legal experts expect court challenges on federal preemption grounds if Pritzker signs the bill. The Farm Bill's hemp provisions include a clause preserving state authority to regulate hemp more restrictively than federal law, but the scope of that authority remains untested in appellate courts. Similar bans in Oregon and Colorado have faced litigation, with mixed preliminary rulings.
Illinois's bill includes a severability clause, allowing portions of the law to remain in effect if courts strike down specific provisions. That drafting choice signals legislative awareness of potential constitutional challenges.
Revenue Implications for State Budget
Restricting intoxicating hemp sales is projected to shift $150 million to $250 million in annual consumer spending back to licensed dispensaries, boosting state cannabis tax revenue. Illinois collected $445 million in adult-use cannabis taxes in fiscal year 2025, a 12% increase over the prior year. Analysts at the Illinois Economic and Fiscal Commission estimate the hemp restrictions could add 8% to 10% to annual cannabis tax receipts if enforcement is consistent.
The bill doesn't create a new tax on hemp products. Revenue gains would come entirely from redirected consumer purchases to the existing 37.5% tax structure on adult-use cannabis sales.
What Happens Next
Pritzker has 60 days to sign, veto, or allow the bill to become law without his signature. His office hasn't issued a public statement on SB 3222. The Illinois Department of Financial and Professional Regulation would begin rulemaking within 90 days of enactment to establish retail enforcement protocols. For full background on Illinois's hemp regulatory framework, see the CannIntel topic hub on Illinois Hemp Regulation.
For complete background, history, and our ongoing coverage of this story:
Open the CannIntel topic hub →Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws

NDLEA Seizes N10.3 Billion in Canadian Cannabis, Arrests Lagos Courier
Nigeria's drug agency intercepted high-grade imported cannabis and methamphetamine in coordinated Lagos operations this week.

DEA Blocks Medical Marijuana Patient From Rescheduling Hearing
The agency denied a petition for a chronic pain patient to testify at the December administrative hearing.

Virginia Cannabis Budget Language Triggers Legal Confusion, Political Fallout
Ambiguous fiscal language in Virginia's 2026-27 budget has sparked legal questions over cannabis retail timelines and regulatory authority.
More from the newsroom

Cannabis Dispensaries Invest in Commercial Cash-Handling Infrastructure
Operators are deploying vault-grade cash systems as banking access stalls and transaction volumes climb.

DEA Blocks Medical Marijuana Patient From Rescheduling Hearings
Agency denied request from longtime MMJ advocate to testify during administrative proceedings on cannabis reclassification.

Little Green Pharma Pivots to Europe as Australian Cannabis Exports Accelerate
The ASX-listed producer is redirecting shipments toward European medical markets as Australia's export pipeline expands.